- Home
- PERF vs CRBU Comparison
PERF vs CRBU Comparison
Compare PERF & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PERF
- CRBU
- Stock Information
- Founded
- PERF 2015
- CRBU 2011
- Country
- PERF Taiwan
- CRBU United States
- Employees
- PERF N/A
- CRBU N/A
- Industry
- PERF Computer Software: Prepackaged Software
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- PERF Technology
- CRBU Health Care
- Exchange
- PERF Nasdaq
- CRBU Nasdaq
- Market Cap
- PERF 191.5M
- CRBU 179.7M
- IPO Year
- PERF N/A
- CRBU 2021
- Fundamental
- Price
- PERF $2.04
- CRBU $2.40
- Analyst Decision
- PERF Buy
- CRBU Strong Buy
- Analyst Count
- PERF 1
- CRBU 3
- Target Price
- PERF $5.00
- CRBU $6.67
- AVG Volume (30 Days)
- PERF 153.7K
- CRBU 1.1M
- Earning Date
- PERF 10-28-2025
- CRBU 11-05-2025
- Dividend Yield
- PERF N/A
- CRBU N/A
- EPS Growth
- PERF 4.52
- CRBU N/A
- EPS
- PERF 0.06
- CRBU N/A
- Revenue
- PERF $64,369,000.00
- CRBU $9,121,000.00
- Revenue This Year
- PERF $15.99
- CRBU $9.23
- Revenue Next Year
- PERF $14.39
- CRBU N/A
- P/E Ratio
- PERF $33.75
- CRBU N/A
- Revenue Growth
- PERF 13.19
- CRBU N/A
- 52 Week Low
- PERF $1.51
- CRBU $0.66
- 52 Week High
- PERF $3.44
- CRBU $3.00
- Technical
- Relative Strength Index (RSI)
- PERF 53.53
- CRBU 65.63
- Support Level
- PERF $1.85
- CRBU $2.17
- Resistance Level
- PERF $1.95
- CRBU $2.39
- Average True Range (ATR)
- PERF 0.07
- CRBU 0.19
- MACD
- PERF 0.01
- CRBU 0.04
- Stochastic Oscillator
- PERF 73.91
- CRBU 99.33
About PERF Perfect Corp.
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.